Management of Intense Pruritus in Mycosis Fungoides

Introduction to Treatment

The American Academy of Dermatology recommends using gabapentin (900-3600 mg daily) or pregabalin (25-150 mg daily) as first-line systemic therapy for intense pruritus associated with mycosis fungoides, combined with high-potency topical corticosteroids and emollients, while avoiding sedating antihistamines and cyclosporine 1, 2, 3

Apply high-lipid content emollients at least once daily to the entire body to address xerosis and impaired barrier function 2
Use potent topical corticosteroids such as clobetasol propionate 0.05% or moderate-potency agents like clobetasone butyrate 3-4 times daily to affected areas 4, 2, 3
Consider topical menthol preparations for counter-irritant effects that provide immediate pruritus relief 1, 3

Gabapentin 900-3600 mg daily is the preferred systemic agent for lymphoma-associated pruritus 1, 2, 3
Alternative: Pregabalin 25-150 mg daily if gabapentin is not tolerated 2, 3
Non-sedating antihistamines: fexofenadine 180 mg daily, loratadine 10 mg daily, or cetirizine 10 mg daily 1, 2, 3
Consider combination H1/H2 antagonist therapy (e.g., fexofenadine plus cimetidine) for enhanced effect 3
Cimetidine alone has specific evidence in lymphoma-associated pruritus 1

Do not use cyclosporin for pruritus relief in mycosis fungoides, as evidence suggests it may cause rapid disease progression 5
Never use sedating antihistamines (hydroxyzine, diphenhydramine) long-term due to fall risk and potential dementia association 1, 2
Avoid crotamiton cream, topical capsaicin, and calamine lotion—these are ineffective for lymphoma-associated pruritus 1, 3

Measure pruritus using validated tools (visual analog scale, Skindex-29, or Skindex-16) at baseline and follow-up 8, 9, 10
All pruritus measurements must be done when antipruritic agents are at stable doses or discontinued to accurately assess treatment efficacy 8, 9, 10
Correlate pruritus changes with disease response, as improvement may reflect disease control rather than direct antipruritic effect 8, 9, 10

Phototherapy (PUVA or narrowband UVB) provides both disease control and pruritus relief 6, 4
However, patients with erythrodermic MF/SS are often intolerant of phototherapy due to aggravation of pruritus 7, 4
If starting retinoids (bexarotene, acitretin) during phototherapy, reduce UVL dose to one-third to one-half due to photosensitization risk 6
Take potentially photosensitizing medications after UVL sessions when possible 6
Patients with erythrodermic disease may experience paradoxical worsening of pruritus with phototherapy 7, 4